Chris Aiken, MD(@chrisaikenmd) 's Twitter Profileg
Chris Aiken, MD

@chrisaikenmd

Editor-in-Chief: Carlat Psychiatry Report. Director: Mood Treatment Center. Never received pharma funding. Posting a daily dose of practice-changing research.

ID:1536098282929258500

linkhttp://www.moodtreatmentcenter.com calendar_today12-06-2022 21:29:27

2,1K Tweets

5,0K Followers

1,0K Following

Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Amphetamines raise the risk of death.

So it's alarming that ~1 million amphetamines were prescribed on discharge from the ED, often with opioids:
pubmed.ncbi.nlm.nih.gov/36738570

Rising rates likely reflect the scarcity of outpatient resources

Amphetamines raise the risk of #opioid #overdose death. So it's alarming that ~1 million amphetamines were prescribed on discharge from the ED, often with opioids: pubmed.ncbi.nlm.nih.gov/36738570 Rising rates likely reflect the scarcity of outpatient #psychiatry resources
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Update on
1. Large, rapid effect in
2. Mixed results in
3. Preliminary trials in , , use
4. Toxicity (liver/bladder/cognition) with high-dose recreational use

From review by Owen Muir et al:
pubmed.ncbi.nlm.nih.gov/38518272

Update on #ketamine 1. Large, rapid effect in #depression 2. Mixed results in #PTSD 3. Preliminary trials in #alcohol, #opioid, #cocaine use 4. Toxicity (liver/bladder/cognition) with high-dose recreational use From review by Owen Muir et al: pubmed.ncbi.nlm.nih.gov/38518272
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

New use for fluoxetine (Prozac).

It treated refractory bed-wetting in children in this RCT, but the benefit declined over time (in primary monosymptomatic nocturnal enuresis):
pubmed.ncbi.nlm.nih.gov/36043350

Need to weigh against risks of antidep in children

New use for fluoxetine (Prozac). It treated refractory bed-wetting in children in this RCT, but the benefit declined over time (in primary monosymptomatic nocturnal enuresis): pubmed.ncbi.nlm.nih.gov/36043350 Need to weigh against risks of antidep in children #psychiatry #Pediatrics
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

1st lumateperone (Caplyta) RCT in major :
> Aug , medium effect size (0.6)
> 6 wks, 485 pts, 1-2 failed med trials
> Fatigue, dry mouth, tremor main side effects

Data unpublished, summary here:
ir.intracellulartherapies.com/news-releases/…

2nd trial anticipated in summer.

1st lumateperone (Caplyta) RCT in major #depression: > Aug #antidepressants, medium effect size (0.6) > 6 wks, 485 pts, 1-2 failed med trials > Fatigue, dry mouth, tremor main side effects Data unpublished, summary here: ir.intracellulartherapies.com/news-releases/… 2nd trial anticipated in summer.
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Modafinil (Provigil) s not an energy pill.

It has failed in many trials of medical , including this new, large phase-III trial in cancer-fatigue:
ncbi.nlm.nih.gov/pmc/articles/P…

Also failed in RCTs of antipsychotic-related fatigue

Modafinil (Provigil) s not an energy pill. It has failed in many trials of medical #fatigue, including this new, large phase-III trial in cancer-fatigue: ncbi.nlm.nih.gov/pmc/articles/P… Also failed in RCTs of antipsychotic-related fatigue #psychiatry #medicine
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

What if people waited 4 wks instead of the usual 1 wk to quit after starting verenicline (Chantix)?

A lot of theory supports this idea, but this large trial failed to find any lasting benefit with the delayed-quit approach:
ncbi.nlm.nih.gov/pmc/articles/P…

What if people waited 4 wks instead of the usual 1 wk to quit #nicotine after starting verenicline (Chantix)? A lot of theory supports this idea, but this large trial failed to find any lasting benefit with the delayed-quit approach: ncbi.nlm.nih.gov/pmc/articles/P… #quitsmoking
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Review lists saffron's results from small, randomized trials:
> Beat placebo in , cognition, insomnia
> Equaled standard meds in , ,
> Well tolerated
pubmed.ncbi.nlm.nih.gov/38424688

Recommended products (surprisingly, low cost):
moodtreatmentcenter.com/products

Review lists saffron's results from small, randomized trials: > Beat placebo in #depression, cognition, insomnia > Equaled standard meds in #anxiety, #ADHD, #OCD > Well tolerated pubmed.ncbi.nlm.nih.gov/38424688 Recommended products (surprisingly, low cost): moodtreatmentcenter.com/products
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

A green extract (l-theanine) reduced biological measures of in this study of 120 volunteers:
jstage.jst.go.jp/article/jnsv/6…

Learn how to use l-theanine:
moodtreatmentcenter.com/products

Or just drink :
psychiatrictimes.com/view/cognitive…

A green #tea extract (l-theanine) reduced biological measures of #stress in this study of 120 volunteers: jstage.jst.go.jp/article/jnsv/6… Learn how to use l-theanine: moodtreatmentcenter.com/products Or just drink #Matcha: psychiatrictimes.com/view/cognitive… #mentalhealth
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Antipsychotics are often used for , but you have to look hard to find evidence that they work.

You won’t find it in this analysis of olanzapine (Zyprexa):
pubmed.ncbi.nlm.nih.gov/36845642

Antipsychotics are often used for #delirium, but you have to look hard to find evidence that they work. You won’t find it in this analysis of olanzapine (Zyprexa): pubmed.ncbi.nlm.nih.gov/36845642 #psychiatry #antipsychotic #medicine
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Fascinating that psychiatrists (KOLs) in Europe are promoting Silexan (lavender extract) for heavily. In the US it is over the counter and largely unknown

My take: Bias on both sides. Stick to the evidence. And let’s keep learning from the international community

account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Silexan (lavender extract approved for anxiety in Europe) is more effective than SSRIs in head-to-head trials & worked better for more severe in new analysis of 5 RCTs:
pubmed.ncbi.nlm.nih.gov/38425206

Podcast:
thecarlatreport.com/blogs/2-the-ca…

How to use:
moodtreatmentcenter.com/products

Silexan (lavender extract approved for anxiety in Europe) is more effective than SSRIs in head-to-head trials & worked better for more severe #anxiety in new analysis of 5 RCTs: pubmed.ncbi.nlm.nih.gov/38425206 Podcast: thecarlatreport.com/blogs/2-the-ca… How to use: moodtreatmentcenter.com/products
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

The first placebo-trial of low-dose for cognitive impairment came out 12 years ago, and this study followed up on 59% of the cohort:
ncbi.nlm.nih.gov/pmc/articles/P…

Benefits were sustained, even after stopping lithium.

The first placebo-trial of low-dose #lithium for cognitive impairment came out 12 years ago, and this study followed up on 59% of the cohort: ncbi.nlm.nih.gov/pmc/articles/P… Benefits were sustained, even after stopping lithium. #memory #psychiatry #neurology
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

First case of ketamine tolerance from Mayo Clinic:
pubmed.ncbi.nlm.nih.gov/38597410

To stay well, the patient required increasing frequency of , until it no longer worked after 5 years.

First case of ketamine tolerance from Mayo Clinic: pubmed.ncbi.nlm.nih.gov/38597410 To stay well, the patient required increasing frequency of #ketamine, until it no longer worked after 5 years. #depression #psychiatry
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Two psych meds held promise for : lithium and fluvoxamine, an antidepressant. So far, the data favors :
ncbi.nlm.nih.gov/pmc/articles/P…

but not the SSRI:
pubmed.ncbi.nlm.nih.gov/37002592

Two psych meds held promise for #COVID: lithium and fluvoxamine, an #SSRI antidepressant. So far, the data favors #lithium: ncbi.nlm.nih.gov/pmc/articles/P… but not the SSRI: pubmed.ncbi.nlm.nih.gov/37002592 #psychiatry
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Update on :
1. Large effect in assisted therapy (full remission in 61-71%)
2. Preliminary trials in , social , use disorder
3. All trials from the same company (Lykos/MAPS)

From a review by Owen Scottt Muir, MD, DFAACAP et al:
pubmed.ncbi.nlm.nih.gov/38518271

Update on #MDMA: 1. Large effect in #PTSD assisted therapy (full remission in 61-71%) 2. Preliminary trials in #autism, social #anxiety, #alcohol use disorder 3. All trials from the same company (Lykos/MAPS) From a review by @ScottMuirMD et al: pubmed.ncbi.nlm.nih.gov/38518271
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Clonidine treats ADHD, but does it help cognition in ? A new, small RCT suggests yes, as do a series of studies with the similar med guanfacine:
sciencedirect.com/science/articl…

Clonidine also helps psychogenic polydipsia, common in psychosis

Clonidine treats ADHD, but does it help cognition in #schizophrenia? A new, small RCT suggests yes, as do a series of studies with the similar med guanfacine: sciencedirect.com/science/articl… Clonidine also helps psychogenic polydipsia, common in psychosis
account_circle